First half of 2023: Boehringer Ingelheim sees strong growth and expansion in key therapy areas
Business Wire India Areas of progress include rare skin diseases, cardio-renal-metabolic diseases, and immuno-oncology Jardiance® and NexGard® portfolios drive strong growth First half 2023 net sales up 9.7 percent at…